Cancer treatment remains a lottery as HAs fail to follow NICE guidelines

More than 20 per cent of health authorities are still not following national guidelines for the drug treatment of breast and ovarian cancer, according to a survey.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here